Key result
Robotic cardiac surgery is feasible and safe, offering shorter hospitalizations and fewer complications but at higher costs and longer procedure times compared to classic techniques.
Why the study?
The current application and future perspectives of medical robots in cardiac surgery are not comprehensively reviewed and analyzed, including market and clinical readiness aspects.
Answers are grounded in this paper and cite their sources.
Medical robots offer new standards and opportunities for treatment. This paper presents a review of the literature and market information on the current situation and future perspectives for the applications of robots in cardiac surgery. Currently in the United States, only 10% of thoracic surgical procedures are conducted using robots, while globally this value remains below 1%. Cardiac and thoracic surgeons use robotic surgical systems increasingly often. The goal is to perform more than one hundred thousand minimally invasive robotic surgical procedures every year. A surgical robot can be used by surgical teams on a rotational basis. The market of surgical robots used for cardiovascular and lung surgery was worth 72.2 million dollars in 2014 and is anticipated to reach 2.2 billion dollars by 2021. The analysis shows that Poland should have more than 30 surgical robots. Moreover, Polish medical teams are ready for the introduction of several robots into the field of cardiac surgery. We hope that this market will accommodate the Polish Robin Heart robots as well.
No takes yet. Share an insight, caveat, or question.
Kroczek et al. (2017) conducted a review in Cardiac surgery. Robotic surgical systems vs. Classic surgical techniques was evaluated. Robotic cardiac surgery is feasible and safe, offering shorter hospitalizations and fewer complications but at higher costs and longer procedure times compared to classic techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: